<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36880220</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2045-7634</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Cancer medicine</Title><ISOAbbreviation>Cancer Med</ISOAbbreviation></Journal><ArticleTitle>Association between rapid renal function deterioration and cancer mortality in the elderly: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>10008</StartPage><EndPage>10019</EndPage><MedlinePgn>10008-10019</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cam4.5735</ELocationID><Abstract><AbstractText Label="BACKGROUND">Kidney function is associated with clinical outcomes in patients with cancer.</AbstractText><AbstractText Label="OBJECTIVES">This study aimed to assess the association between kidney function decline and cancer-related mortality among community-dwelling elderly individuals.</AbstractText><AbstractText Label="DESIGN">This was a retrospective longitudinal cohort study.</AbstractText><AbstractText Label="PARTICIPANTS">The 61,988 participants were from an elderly health examination database in Taipei City from 2005 to 2012.</AbstractText><AbstractText Label="MEASUREMENTS">Multivariable logistic regression was used to assess the association between baseline covariates and rapidly deteriorating estimated glomerular filtration rate (eGFR). In addition, Cox proportional hazards model and the Fine-Gray model were used to quantify the effects of covariates on total cancer mortality and six specific cancer mortalities.</AbstractText><AbstractText Label="RESULTS">During the follow-up period, 1482 participants died of cancer. Their baseline average eGFR was 73.8&#x2009;&#xb1;&#x2009;19.9&#x2009;mL/min/1.73&#x2009;m<sup>2</sup> , and 18.3% had rapid renal function decline (&#x2265;5&#x2009;mL/min/1.73&#x2009;m<sup>2</sup> per year). Rapid renal function decline was positively related to age, baseline eGFR, proteinuria, hypertension, waist circumferences, high log triglyceride levels, and diabetes mellitus (DM) history. In Cox proportional hazard models, participants with rapid eGFR decline had an increased risk of cancer mortality [hazard ratio (95% CI): 1.97 (1.73, 2.24); p&#x2009;&lt;&#x2009;0.001] compared to those without rapid eGFR decline. In the analysis of site-specific cancer mortality risk, rapid eGFR decline was associated with six site-specific cancer mortality, namely gastrointestinal tract, hepatobiliary, lung, prostate, urinary tract, and hematological malignancies.</AbstractText><AbstractText Label="CONCLUSIONS">Elderly individuals with rapid kidney function decline had higher cancer mortality risks. Serial assessments of dynamic changes in eGFR might provide information relevant for cancer prognosis.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Cancer Medicine published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>I-Ching</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Yi-Chi</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Research Center for Humanities and Social Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Hsu</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center of Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Science and Technology, College of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, National Sun Yat-sen University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Ta-Chien</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0002-1685-783X</Identifier><AffiliationInfo><Affiliation>Research Center for Humanities and Social Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, National Sun Yat-sen University.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Public Health, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Med</MedlineTA><NlmUniqueID>101595310</NlmUniqueID><ISSNLinking>2045-7634</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cancer mortality</Keyword><Keyword MajorTopicYN="N">eGFR</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">rapid kidney function decline</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>3</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36880220</ArticleId><ArticleId IdType="pmc">PMC10166944</ArticleId><ArticleId IdType="doi">10.1002/cam4.5735</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394&#x2010;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7&#x2010;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">35020204</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ministry of Health and Welfare, T
. The cause of death in Taiwan in 2020. 2021. Accessed February 2, 2022. https://dep.mohw.gov.tw/dos/lp&#x2010;5069&#x2010;113.html
</Citation></Reference><Reference><Citation>Fowler H, Belot A, Ellis L, et al. Comorbidity prevalence among cancer patients: a population&#x2010;based cohort study of four cancers. BMC Cancer. 2020;20:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6986047</ArticleId><ArticleId IdType="pubmed">31987032</ArticleId></ArticleIdList></Reference><Reference><Citation>Launay&#x2010;Vacher V, Oudard S, Janus N, et al. Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer. 2007;110:1376&#x2010;1384.</Citation><ArticleIdList><ArticleId IdType="pubmed">17634949</ArticleId></ArticleIdList></Reference><Reference><Citation>Iff S, Craig JC, Turner R, et al. Reduced estimated GFR and cancer mortality. Am J Kidney Dis. 2014;63:23&#x2010;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">23993153</ArticleId></ArticleIdList></Reference><Reference><Citation>Na SY, Sung JY, Chang JH, et al. Chronic kidney disease in cancer patients: an independent predictor of cancer&#x2010;specific mortality. Am J Nephrol. 2011;33:121&#x2010;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">21242672</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng PH, Hung KY, Huang HL, Chen JH, Sung PK, Huang KC. Cancer&#x2010;specific mortality in chronic kidney disease: longitudinal follow&#x2010;up of a large cohort. Clin J Am Soc Nephrol. 2011;6:1121&#x2010;1128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3087779</ArticleId><ArticleId IdType="pubmed">21511834</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Li HY, Zhou Q, et al. Renal function and all&#x2010;cause mortality risk among cancer patients. Medicine (Baltimore). 2016;95:e3728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4902436</ArticleId><ArticleId IdType="pubmed">27196494</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok Y, Matsushita K, Sang Y, et al. Association of Kidney Disease Measures with cause&#x2010;specific mortality: the Korean heart study. PLoS One. 2016;11:e0153429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4836674</ArticleId><ArticleId IdType="pubmed">27092943</ArticleId></ArticleIdList></Reference><Reference><Citation>Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003;107:87&#x2010;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">12515748</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata M. Inflammation and cancer. Environ Health Prev Med. 2018;23:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6195709</ArticleId><ArticleId IdType="pubmed">30340457</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Aly Z, Zeringue A, Fu J, et al. Rate of kidney function decline associates with mortality. J Am Soc Nephrol. 2010;21:1961&#x2010;1969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014010</ArticleId><ArticleId IdType="pubmed">20947634</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J. Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol. 2009;20:2617&#x2010;2624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2794225</ArticleId><ArticleId IdType="pubmed">19892932</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifkin DE, Shlipak MG, Katz R, et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med. 2008;168:2212&#x2010;2218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2879064</ArticleId><ArticleId IdType="pubmed">19001197</ArticleId></ArticleIdList></Reference><Reference><Citation>Turin TC, Coresh J, Tonelli M, et al. Change in the estimated glomerular filtration rate over time and risk of all&#x2010;cause mortality. Kidney Int. 2013;83:684&#x2010;691.</Citation><ArticleIdList><ArticleId IdType="pubmed">23344477</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Zhang L, Zuo L, Liu L, Wang H. Mortality and renal function decline among a community&#x2010;based Chinese population with normal or mildly impaired renal function. Nephrol Dial Transplant. 2011;26:2847&#x2010;2852.</Citation><ArticleIdList><ArticleId IdType="pubmed">21285130</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero JM, Bover J, Fite J, et al. The modification of diet in renal disease 4&#x2010;calculated glomerular filtration rate is a better prognostic factor of cardiovascular events than classical cardiovascular risk factors in patients with peripheral arterial disease. J Vasc Surg. 2012;56:1324&#x2010;1330.</Citation><ArticleIdList><ArticleId IdType="pubmed">22795519</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO . KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:5&#x2010;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">23989362</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods LM, Rachet B, Ellis L, Coleman MP. Full dates (day, month, year) should be used in population&#x2010;based cancer survival studies. Int J Cancer. 2012;131:E1120&#x2010;E1124.</Citation><ArticleIdList><ArticleId IdType="pubmed">22438030</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2017.</Citation></Reference><Reference><Citation>Therneau TM. A Package for Survival Analysis in S. version 2.38 edn. 2015.</Citation></Reference><Reference><Citation>Berry SD, Ngo L, Samelson EJ, Kiel DP. Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc. 2010;58:783&#x2010;787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2873048</ArticleId><ArticleId IdType="pubmed">20345862</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray B. cmprsk: subdistribution Analysis of Competing Risks Volume R package version 2.2&#x2010;9. 2019.</Citation></Reference><Reference><Citation>Koraishy FM, Hooks&#x2010;Anderson D, Salas J, Rauchman M, Scherrer JF. Fast GFR decline and progression to CKD among primary care patients with preserved GFR. Int Urol Nephrol. 2018;50:501&#x2010;508.</Citation><ArticleIdList><ArticleId IdType="pubmed">29404927</ArticleId></ArticleIdList></Reference><Reference><Citation>Baba M, Shimbo T, Horio M, et al. Longitudinal study of the decline in renal function in healthy subjects. PLoS One. 2015;10:e0129036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4464887</ArticleId><ArticleId IdType="pubmed">26061083</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien KL, Lin HJ, Lee BC, Hsu HC, Lee YT, Chen MF. A prediction model for the risk of incident chronic kidney disease. Am J Med. 2010;123:836&#x2010;846.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">20800153</ArticleId></ArticleIdList></Reference><Reference><Citation>Halbesma N, Brantsma AH, Bakker SJL, et al. Gender differences in predictors of the decline of renal function in the general population. Kidney Int. 2008;74:505&#x2010;512.</Citation><ArticleIdList><ArticleId IdType="pubmed">18496511</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamei K, Konta T, Hirayama A, et al. A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community&#x2010;based population. Nephrol Dial Transplant. 2014;29:2286&#x2010;2292.</Citation><ArticleIdList><ArticleId IdType="pubmed">25061123</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefansson VTN, Schei J, Solbu MD, Jenssen TG, Melsom T, Eriksen BO. Metabolic syndrome but not obesity measures are risk factors for accelerated age&#x2010;related glomerular filtration rate decline in the general population. Kidney Int. 2018;93:1183&#x2010;1190.</Citation><ArticleIdList><ArticleId IdType="pubmed">29395334</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhee JH, Kee YK, Park S, et al. High&#x2010;protein diet with renal hyperfiltration is associated with rapid decline rate of renal function: a community&#x2010;based prospective cohort study. Nephrol Dial Transplant. 2020;35:98&#x2010;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">31172186</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Cui L, Ye P, Li J, Wu S, Luo Y. Change of kidney function is associated with all&#x2010;cause mortality and cardiovascular diseases: results from the Kailuan study. J Am Heart Assoc. 2018;7:e010596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6404220</ArticleId><ArticleId IdType="pubmed">30608199</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha SK, Lee SB, Won J, et al. Correlation between oxidative stress, nutrition, and cancer initiation. Int J Mol Sci. 2017;18:1544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536032</ArticleId><ArticleId IdType="pubmed">28714931</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara M, Tanaka S, Taniguchi M, et al. The association between dialysis dose and risk of cancer death in patients undergoing hemodialysis: the Q&#x2010;cohort study. Intern Med. 2020;59:1141&#x2010;1148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270758</ArticleId><ArticleId IdType="pubmed">32051383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheflin AM, Whitney AK, Weir TL. Cancer&#x2010;promoting effects of microbial dysbiosis. Curr Oncol Rep. 2014;16:406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4180221</ArticleId><ArticleId IdType="pubmed">25123079</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger NA, Savvides P, Koroukian SM, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc. 2006;117:147&#x2010;155. discussion 155&#x2010;156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1500929</ArticleId><ArticleId IdType="pubmed">18528470</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66:337&#x2010;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">26891458</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;gaard M, Thomsen RW, Bossen KS, S&#xf8;rensen HT, N&#xf8;rgaard M. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2013;5:3&#x2010;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820483</ArticleId><ArticleId IdType="pubmed">24227920</ArticleId></ArticleIdList></Reference><Reference><Citation>Malyszko J, Tesarova P, Capasso G, Capasso A. The link between kidney disease and cancer: complications and treatment. Lancet. 2020;396:277&#x2010;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">32711803</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>